Fantastic trading at 36.25% premium currently.Seeing PJ on board to the extent that he is, has obviously inspired some confidence.Long may it continue.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%